1-20 of 24
Peter H. Wiernik
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dynamics of Leukemia Stem-like Cell Extinction in Acute Promyelocytic Leukemia

Benjamin Werner, Robert E. Gallagher, Elisabeth M. Paietta, Mark R. Litzow, Martin S. Tallman, Peter H. Wiernik, James L. Slack, Cheryl L. Willman, Zhuoxin Sun, Arne Traulsen, David Dingli
Journal: Cancer Research
Cancer Res (2014) 74 (19): 5386–5396.
https://doi.org/10.1158/0008-5472.CAN-14-1210
Published: 30 September 2014
View article titled, Dynamics of Leukemia Stem-like Cell Extinction in Acute Promyelocytic Leukemia
Open the PDF for Dynamics of Leukemia Stem-like Cell Extinction in Acute Promyelocytic Leukemia in another window
Journal Articles

Anticipation in families with Hodgkin’s and non-Hodgkin’s lymphoma in their pedigree

Doru T. Alexandrescu, Alexandria Garino, Kelly Brown, Peter H. Wiernik
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 700–701.
Published: 15 April 2006
View article titled, Anticipation in families with Hodgkin’s and non-Hodgkin’s lymphoma in their pedigree
Journal Articles

Biological significance of overexpression of carbonic anhydrase IX in renal cell carcinoma

Thambi Dorai, Ihor Sawczuk, Peter H. Wiernik, Janice P. Dutcher
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 241.
Published: 01 May 2005
View article titled, Biological significance of overexpression of carbonic anhydrase IX in renal cell carcinoma
Journal Articles

Therapeutic potential of curcumin in prostate cancer: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.

Thambi Dorai, Janice P. Dutcher, David W. Dempster, Peter H. Wiernik
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 477–478.
Published: 01 April 2004
View article titled, Therapeutic potential of curcumin in prostate cancer: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells.
Journal Articles

Clonal isolation of different strains of mouse mammary tumor virus (MMTV)-like DNA sequences from both the breast tumors and non-Hodgkin’s lymphomas of individual patients diagnosed with both malignancies

Polly R. Etkind, Alexandre F. Stewart, Thambi Dorai, Daniel J. Purcell, Peter H. Wiernik
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1102.
Published: 01 April 2004
View article titled, Clonal isolation of different strains of mouse mammary tumor virus (MMTV)-like DNA sequences from both the breast tumors and non-Hodgkin’s lymphomas of individual patients diagnosed with both malignancies
Journal Articles

Constitutive Expression of Cellular Retinoic Acid Binding Protein II and Lack of Correlation with Sensitivity to All-Trans Retinoic Acid in Acute Promyelocytic Leukemia Cells

Da-Cheng Zhou, Steven J. Hallam, Sandra J. Lee, Robert S. Klein, Peter H. Wiernik, Martin S. Tallman, Robert E. Gallagher
Journal: Cancer Research
Cancer Res (1998) 58 (24): 5770–5776.
Published: 01 December 1998
View article titled, Constitutive Expression of Cellular Retinoic Acid Binding Protein II and Lack of Correlation with Sensitivity to All-<em>Trans</em> Retinoic Acid in Acute Promyelocytic Leukemia Cells
Open the PDF for Constitutive Expression of Cellular Retinoic Acid Binding Protein II and Lack of Correlation with Sensitivity to All-<em>Trans</em> Retinoic Acid in Acute Promyelocytic Leukemia Cells in another window
Journal Articles

Expression of the Macrophage Growth Factor, CSF-1 and Its Receptor c-fms by a Hodgkin's Disease-derived Cell Line and Its Variants

Elisabeth Paietta, Janis Racevskis, E. Richard Stanley, Michael Andreeff, Peter Papenhausen, Peter H. Wiernik
Journal: Cancer Research
Cancer Res (1990) 50 (7): 2049–2055.
Published: 01 April 1990
View article titled, Expression of the Macrophage Growth Factor, CSF-1 and Its Receptor c-<em>fms</em> by a Hodgkin's Disease-derived Cell Line and Its Variants
Open the PDF for Expression of the Macrophage Growth Factor, CSF-1 and Its Receptor c-<em>fms</em> by a Hodgkin's Disease-derived Cell Line and Its Variants in another window
Journal Articles

Phase I Trial of 5-Fluorouracil and Recombinant α2a-Interferon in Patients with Advanced Colorectal Carcinoma

Scott Wadler, Mark Goldman, Anne Lyver, Peter H. Wiernik
Journal: Cancer Research
Cancer Res (1990) 50 (7): 2056–2059.
Published: 01 April 1990
View article titled, Phase I Trial of 5-Fluorouracil and Recombinant α<sub>2a</sub>-Interferon in Patients with Advanced Colorectal Carcinoma
Open the PDF for Phase I Trial of 5-Fluorouracil and Recombinant α<sub>2a</sub>-Interferon in Patients with Advanced Colorectal Carcinoma in another window
Journal Articles

Partial Reversal of Doxorubicin Resistance by Forskolin and 1,9-Dideoxyforskolin in Murine Sarcoma S180 Variants

Scott Wadler, Peter H. Wiernik
Journal: Cancer Research
Cancer Res (1988) 48 (3): 539–543.
Published: 01 February 1988
View article titled, Partial Reversal of Doxorubicin Resistance by Forskolin and 1,9-Dideoxyforskolin in Murine Sarcoma S180 Variants
Open the PDF for Partial Reversal of Doxorubicin Resistance by Forskolin and 1,9-Dideoxyforskolin in Murine Sarcoma S180 Variants in another window
Journal Articles

A Membrane-bound Lectin Responsive to Monocytic Maturation in the Promyelocytic Leukemia Cell Line HL-60

Elisabeth Paietta, Robert Gallagher, Peter H. Wiernik, Richard J. Stockert
Journal: Cancer Research
Cancer Res (1988) 48 (2): 280–287.
Published: 01 January 1988
View article titled, A Membrane-bound Lectin Responsive to Monocytic Maturation in the Promyelocytic Leukemia Cell Line HL-60
Open the PDF for A Membrane-bound Lectin Responsive to Monocytic Maturation in the Promyelocytic Leukemia Cell Line HL-60 in another window
Journal Articles

Severe Hypovitaminosis C Occurring as the Result of Adoptive Immunotherapy with High-Dose Interleukin 2 and Lymphokine-activated Killer Cells

Stuart L. Marcus, Janice P. Dutcher, Elisabeth Paietta, Niculae Ciobanu, Janice Strauman, Peter H. Wiernik, Seymour H. Hutner, Oscar Frank, Herman Baker
Journal: Cancer Research
Cancer Res (1987) 47 (15): 4208–4212.
Published: 01 August 1987
View article titled, Severe Hypovitaminosis C Occurring as the Result of Adoptive Immunotherapy with High-Dose Interleukin 2 and Lymphokine-activated Killer Cells
Open the PDF for Severe Hypovitaminosis C Occurring as the Result of Adoptive Immunotherapy with High-Dose Interleukin 2 and Lymphokine-activated Killer Cells in another window
Journal Articles

Hodgkin's Cell Lectin: An Ectosialyltransferase and Lymphocyte Agglutinant Related to the Hepatic Asialoglycoprotein Receptor

Elisabeth Paietta, Ann L. Hubbard, Peter H. Wiernik, Volker Diehl, Richard J. Stockert
Journal: Cancer Research
Cancer Res (1987) 47 (9): 2461–2467.
Published: 01 May 1987
View article titled, Hodgkin's Cell Lectin: An Ectosialyltransferase and Lymphocyte Agglutinant Related to the Hepatic Asialoglycoprotein Receptor
Open the PDF for Hodgkin's Cell Lectin: An Ectosialyltransferase and Lymphocyte Agglutinant Related to the Hepatic Asialoglycoprotein Receptor in another window
Journal Articles

Phase I Clinical and Pharmacokinetic Study of Taxol

Peter H. Wiernik, Edward L. Schwartz, Janice J. Strauman, Janice P. Dutcher, Richard B. Lipton, Elisabeth Paietta
Journal: Cancer Research
Cancer Res (1987) 47 (9): 2486–2493.
Published: 01 May 1987
View article titled, Phase I Clinical and Pharmacokinetic Study of Taxol
Open the PDF for Phase I Clinical and Pharmacokinetic Study of Taxol in another window
Journal Articles

Chromosomal Alterations in Acute Leukemia Patients Studied with Improved Culture Methods

Joseph R. Testa, Shinichi Misawa, Nobuo Oguma, Keri Van Sloten, Peter H. Wiernik
Journal: Cancer Research
Cancer Res (1985) 45 (1): 430–434.
Published: 01 January 1985
View article titled, Chromosomal Alterations in Acute Leukemia Patients Studied with Improved Culture Methods
Open the PDF for Chromosomal Alterations in Acute Leukemia Patients Studied with Improved Culture Methods in another window
Journal Articles

Clinical Correlations of Leukemic Clonogenic Cell Chemosensitivity Assessed by in Vitro Continuous Exposure to Drugs

Chan H. Park, Peter H. Wiernik, Francis S. Morrison, Mammo Amare, Kerry Van Sloten, Thomas R. Maloney
Journal: Cancer Research
Cancer Res (1983) 43 (5): 2346–2349.
Published: 01 May 1983
View article titled, Clinical Correlations of Leukemic Clonogenic Cell Chemosensitivity Assessed by <em>in Vitro</em> Continuous Exposure to Drugs
Open the PDF for Clinical Correlations of Leukemic Clonogenic Cell Chemosensitivity Assessed by <em>in Vitro</em> Continuous Exposure to Drugs in another window
Journal Articles

Clinical Phase I–II and Pharmacokinetic Study of High-Dose Thymidine Given by Continuous Intravenous Infusion

Delia F. Chiuten, Peter H. Wiernik, Daniel S. Zaharko, Linda Edwards
Journal: Cancer Research
Cancer Res (1980) 40 (3): 818–822.
Published: 01 March 1980
View article titled, Clinical Phase I–II and Pharmacokinetic Study of High-Dose Thymidine Given by Continuous Intravenous Infusion
Open the PDF for Clinical Phase I–II and Pharmacokinetic Study of High-Dose Thymidine Given by Continuous Intravenous Infusion in another window
Journal Articles

Pharmacokinetic Studies during Phase I Trials of High-Dose Thymidine Infusions

Daniel S. Zaharko, Bruce J. Bolten, Delia Chiuten, Peter H. Wiernik
Journal: Cancer Research
Cancer Res (1979) 39 (12): 4777–4781.
Published: 01 December 1979
View article titled, Pharmacokinetic Studies during Phase I Trials of High-Dose Thymidine Infusions
Open the PDF for Pharmacokinetic Studies during Phase I Trials of High-Dose Thymidine Infusions in another window
Journal Articles

Phase I Trial of N-(Phosphonacetyl)-l-aspartate

Charles Erlichman, John M. Strong, Peter H. Wiernik, Linda M. McAvoy, Martin H. Cohen, Arthur S. Levine, Susan M. Hubbard, Bruce A. Chabner
Journal: Cancer Research
Cancer Res (1979) 39 (10): 3992–3995.
Published: 01 October 1979
View article titled, Phase I Trial of <em>N</em>-(Phosphonacetyl)-<sc>l</sc>-aspartate
Open the PDF for Phase I Trial of <em>N</em>-(Phosphonacetyl)-<sc>l</sc>-aspartate in another window
Journal Articles

Phase I Clinical and Pharmacological Study of 4′-(9-Acridinylamino)-methanesulfon-m-anisidide Using an Intermittent Biweekly Schedule

David A. Van Echo, Delia F. Chiuten, Paul E. Gormley, J. Leonard Lichtenfeld, Mary Scoltock, Peter H. Wiernik
Journal: Cancer Research
Cancer Res (1979) 39 (10): 3881–3884.
Published: 01 October 1979
View article titled, Phase I Clinical and Pharmacological Study of 4′-(9-Acridinylamino)-methanesulfon-<em>m</em>-anisidide Using an Intermittent Biweekly Schedule
Open the PDF for Phase I Clinical and Pharmacological Study of 4′-(9-Acridinylamino)-methanesulfon-<em>m</em>-anisidide Using an Intermittent Biweekly Schedule in another window
Journal Articles

Initial Clinical Trials in Cancer Patients of Polyriboinosinic-Polyribocytidylic Acid Stabilized with Poly-l-lysine, in Carboxymethylcellulose [Poly(ICLC)], a Highly Effective Interferon Inducer

Arthur S. Levine, Mary Sivulich, Peter H. Wiernik, Hilton B. Levy
Journal: Cancer Research
Cancer Res (1979) 39 (5): 1645–1650.
Published: 01 May 1979
View article titled, Initial Clinical Trials in Cancer Patients of Polyriboinosinic-Polyribocytidylic Acid Stabilized with Poly-<sc>l</sc>-lysine, in Carboxymethylcellulose [Poly(ICLC)], a Highly Effective Interferon Inducer
Open the PDF for Initial Clinical Trials in Cancer Patients of Polyriboinosinic-Polyribocytidylic Acid Stabilized with Poly-<sc>l</sc>-lysine, in Carboxymethylcellulose [Poly(ICLC)], a Highly Effective Interferon Inducer in another window